Driver launches with cancer trial matching app

Driver Inc. debuted with a platform to match patients to clinical trials based on tumor and saliva samples and medical records.

The company’s app presents customers with clinical trials for which they are eligible at more than 30 hospitals in the U.S., China and Singapore, including the National Cancer Institute (NCI) and the Chinese National Cancer Center. Patients’ eligibility is determined through an analysis of their medical records along with next-generation sequencing (NGS) and immunohistochemistry (IHC) testing at the company’s CLIA-certified lab...